True Form Medical Group
39180 Farwell Drive · Fremont, CA 94538
4.6(18 Google reviews · 3 in past year)
Forward Health · 734 Mowry Avenue · Fremont, CA 94536
5.0· 39 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Forward Health is a health practice in Fremont, California. Its website carries a headline about future-proofing the body and a prompt to make future health a priority, but the text we could read does not detail specific services. On Google it has a 5.0-star rating across 39 reviews dating back to 2024, with 2 in the past year. Reviewers most often mention results, the staff and a caring manner, and one review mentions tirzepatide. Ask which weight-management options it currently offers.
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Counts computed by RetaMaps from public Google reviews; most recent review 2025-10-02. Read the reviews themselves on the practice's Google listing.
Rated ★5.0 across 39 Google reviews. Of the 36 reviews we analyzed, 36 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
No negative reviews among those we analyzed.
Amrit H.★★★★★2025-10-02Forward Health helped me build a sustainable weight loss plan that actually feels realistic. Their support was genuine and considerate, and they took the time to really listen and personalize everything. Appreciated their guidance!
freddy m.★★★★★2025-08-14The best super helpful and understanding to my needs. I highly recommend forward health
Rebeca O.★★★★★2025-04-08I’m a 48 year old woman and have started my new weight loss journey. For the past 20+years I have been over 300 pounds. I lacked energy and motivation. Since being on tirzepatide I’ve lost a 40 pounds , gonna down in inches and pant sizes and feel great. Some side effects of nausea, headaches but nothing to serious as usually pass quickly. I’ve also started incorporating chair yoga and excercise.
John D.★★★★★2025-04-03After turning 60 and already having a mini stroke and a small heart attack I absolutely had to lose weight. With clearance from my cardiologist I started on your medication. Weight loss has been hard in the past but now it seems easier than ever. I see better and better results week after week. I have a much more positive attitude and I feel much more in control of my future. Thank you for all you have done.
Mike S.★★★★★2025-04-03I've had an exceptional experience at Forward Health. The staff are not only caring and attentive but also incredibly helpful in explaining complex medical concepts in patient-friendly terms. They take the time to address all my questions and concerns, ensuring I feel fully informed and supported. Their approach to healthcare is forward-thinking, focusing on preventative measures and assisting patients in setting and achieving future health goals. If you’re looking to make a lifestyle change, I HIGHLY recommend Forward Health for personalized healthcare.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
39180 Farwell Drive · Fremont, CA 94538
4.6(18 Google reviews · 3 in past year)
1860 Mowry Avenue · Fremont, CA 94538
5.0(76 Google reviews · 34 in past year)
5657 Auto Mall Parkway · Fremont, CA 94538
4.6(176 Google reviews · 43 in past year)
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs